SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Nat Commun. 2020 Nov 26;11(1):6013. doi: 10.1038/s41467-020-19808-4.

Abstract

SARS-CoV-2 variants with spike (S)-protein D614G mutations now predominate globally. We therefore compare the properties of the mutated S protein (SG614) with the original (SD614). We report here pseudoviruses carrying SG614 enter ACE2-expressing cells more efficiently than those with SD614. This increased entry correlates with less S1-domain shedding and higher S-protein incorporation into the virion. Similar results are obtained with virus-like particles produced with SARS-CoV-2 M, N, E, and S proteins. However, D614G does not alter S-protein binding to ACE2 or neutralization sensitivity of pseudoviruses. Thus, D614G may increase infectivity by assembling more functional S protein into the virion.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amino Acid Substitution
  • Angiotensin-Converting Enzyme 2 / metabolism
  • COVID-19 / epidemiology
  • COVID-19 / virology*
  • HEK293 Cells
  • Humans
  • Mutation
  • Pandemics
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / pathogenicity*
  • Spike Glycoprotein, Coronavirus / genetics*
  • Spike Glycoprotein, Coronavirus / metabolism
  • Virion / metabolism*
  • Virus Assembly / genetics*
  • Virus Internalization*

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2